Louis Lucido
Presidente presso BIOCORRX INC.
Patrimonio netto: 2 M $ in data 30/04/2024
Posizioni attive di Louis Lucido
Società | Posizione | Inizio | Fine |
---|---|---|---|
BIOCORRX INC. | Direttore/Membro del Consiglio | 01/03/2019 | - |
Presidente | 31/01/2024 | - | |
Independent Dir/Board Member | 01/03/2019 | 31/01/2024 | |
Court Appointed Special Advocates of Los Angeles | Presidente | - | - |
Direttore/Membro del Consiglio | 30/06/2019 | - | |
Doubleline Leveraged Fund Ltd.
Doubleline Leveraged Fund Ltd. Financial ConglomeratesFinance Doubleline Leveraged Fund Ltd. operates as a pooled investment fund. The company is headquartered in Los Angeles, CA. | Direttore/Membro del Consiglio | - | - |
DoubleLine Leveraged Fund LP
DoubleLine Leveraged Fund LP Investment Trusts/Mutual FundsMiscellaneous DoubleLine Leveraged Fund LP operates as a investment fund. The company is headquartered in Los Angeles, CA. | Direttore/Membro del Consiglio | - | - |
Doubleline Opportunistic Income Fund Ltd.
Doubleline Opportunistic Income Fund Ltd. Investment Trusts/Mutual FundsMiscellaneous Doubleline Opportunistic Income Fund Ltd. provides pooled Investment firm. The company is headquartered in Los Angeles, CA. | Direttore/Membro del Consiglio | - | - |
Junior Achievement of Southern California | Direttore/Membro del Consiglio | 01/06/2013 | - |
826LA | Direttore/Membro del Consiglio | 01/06/2013 | - |
Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY. | Direttore/Membro del Consiglio | 01/07/2016 | - |
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Direttore/Membro del Consiglio | 31/01/2024 | - |
Presidente | 31/01/2024 | - |
Storia della carriera di Louis Lucido
Precedenti posizioni note di Louis Lucido
Società | Posizione | Inizio | Fine |
---|---|---|---|
░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░ ░░░░░ ░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - | - |
Formazione di Louis Lucido
New York University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 18 |
Canada | 2 |
Posizioni
Director/Board Member | 9 |
Chairman | 2 |
Chief Operating Officer | 2 |
Settori
Finance | 6 |
Miscellaneous | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
BIOCORRX INC. | Health Services |
AZN CAPITAL CORP. | Non-Energy Minerals |
Aziende private | 15 |
---|---|
TCW Asset Management Co. LLC
TCW Asset Management Co. LLC Investment ManagersFinance TCW Asset Management Co. LLC (TCW) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded in 1992 and is wholly-owned by The TCW Group, Inc. In 2013, TCW management and private investment funds affiliated with The Carlyle Group (NASDAQ: CG) acquired TCW Group from Société Générale. TCW provides investment management and advice for a wide array of investment strategies for institutional and individual investors through investment advisory accounts, private open- and closed-end commingled investment funds and structured investment vehicles such as collateralized debt obligations. | Finance |
Junior Achievement of Southern California | |
Hyperion Brookfield Asset Management, Inc.
Hyperion Brookfield Asset Management, Inc. Investment ManagersFinance Hyperion Capital Management, Inc. is an investment advisory firm located in New York City that offers a range of investment management services for institutional investors. | Finance |
DoubleLine Capital LP
DoubleLine Capital LP Investment ManagersFinance DoubleLine Capital LP (DoubleLine) is an independent, SEC-registered investment advisor headquartered in Tampa, Florida. The firm was founded by Jeffrey Gundlach and Louis Lucido in 2009. DoubleLine provides a variety of investment management services to institutional clients such as corporate entities, pension plans, Undertakings for the Collective Investment of Transferable Interests (UCITS) funds, registered investment companies and unregistered investment companies, foundations, and public and government entities. | Finance |
Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY. | Commercial Services |
Doubleline Opportunistic Credit Fund
Doubleline Opportunistic Credit Fund Investment Trusts/Mutual FundsMiscellaneous Doubleline Opportunistic Credit Fund operates as a closed-end investment fund or investment trust. The firm invests in debt securities and income-producing investments of any kind, including, without limitation, residential and commercial mortgage-backed securities, asset-backed securities, the United States Government securities, corporate debt, international sovereign debt, and short-term investments. Its investment objective is to seek high total investment return by providing a high level of current income and the potential for capital appreciation. The company was founded on July 22, 2011 and is headquartered in Los Angeles, CA. | Miscellaneous |
826LA | |
Delphi Financial Group, Inc.
Delphi Financial Group, Inc. Investment ManagersFinance Delphi Financial Group, Inc. is an investment advisor headquartered in Wilmington, Delaware. The firm is a subsidiary of Tokio Marine & Nichido Fire Insurance Co., Ltd., itself a subsidiary of Tokio Marine Holdings, Inc. (TYO: 8766) in Japan. Delphi Financial Group was founded by Robert Rosenkranz in 1987 and act as a financial holding firm focused on specialty insurance and insurance-related service businesses in North America. | Finance |
DoubleLine Income Solutions Fund
DoubleLine Income Solutions Fund Investment Trusts/Mutual FundsMiscellaneous DoubleLine Income Solutions Fund is a non-diversified, closed-end management investment company, which engages in the investment to a portfolio of investments selected for their potential to provide high current income, growth of capital, or both. Its investment objective is to provide a high level of current income and its secondary objective is to seek capital appreciation. The company was founded on January 10, 2013 and is headquartered in Los Angeles, CA. | Miscellaneous |
Court Appointed Special Advocates of Los Angeles | |
Doubleline Opportunistic Income Fund Ltd.
Doubleline Opportunistic Income Fund Ltd. Investment Trusts/Mutual FundsMiscellaneous Doubleline Opportunistic Income Fund Ltd. provides pooled Investment firm. The company is headquartered in Los Angeles, CA. | Miscellaneous |
DoubleLine Leveraged Fund LP
DoubleLine Leveraged Fund LP Investment Trusts/Mutual FundsMiscellaneous DoubleLine Leveraged Fund LP operates as a investment fund. The company is headquartered in Los Angeles, CA. | Miscellaneous |
Doubleline Leveraged Fund Ltd.
Doubleline Leveraged Fund Ltd. Financial ConglomeratesFinance Doubleline Leveraged Fund Ltd. operates as a pooled investment fund. The company is headquartered in Los Angeles, CA. | Finance |
DoubleLine Group LP | |
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
- Borsa valori
- Insiders
- Louis Lucido
- Esperienza